| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CSTL | Common Stock | Sale | $184,503 | -7,704 | -3.6% | $23.95 | 207,243 | 01 Dec 2022 | By LLC | F1, F2, F3 |
| holding | CSTL | Common Stock | 830 | 01 Dec 2022 | Direct | ||||||
| holding | CSTL | Common Stock | 97,780 | 01 Dec 2022 | By Daniel Bradbury Irrecovable Descendant's Trust | F4 | |||||
| holding | CSTL | Common Stock | 97,805 | 01 Dec 2022 | By Annette Bradbury Irrecovable Descendant's Trust | F5 |
| Id | Content |
|---|---|
| F1 | The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC on June 8, 2022. |
| F2 | This transaction was executed in multiple trades at prices ranging from $23.405 to $24.390, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. |
| F4 | Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |
| F5 | Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. |